Cardiac biomarkers are proteins released into the bloodstream during myocardial injury, serving as measurable indicators of cardiac cell damage. They are crucial in diagnosing acute coronary syndromes, guiding treatment decisions, and assessing prognosis. Troponins, the most specific biomarkers, rise in myocardial infarction but can also elevate in other cardiac conditions.